Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 62101-62150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06304233
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
N/A
Active, not recruiting
120 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2038
3 conditions
2 sponsors
2 locations
NCT06123884
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
PHASE2/PHASE3
Recruiting
526 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT06183021
The Effect of Cryotherapy on the Outcome of Pulpotomy and Root Canal Treatment
NA
Recruiting
144 participants
Started: Dec 13, 2023 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT06127446
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
N/A
Recruiting
300 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2031
1 condition
9 sponsors
8 locations
NCT06088030
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
PHASE2
Recruiting
50 participants
Started: Dec 13, 2023 · Completed: Dec 14, 2031
3 conditions
2 sponsors
1 location
NCT06101342
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
PHASE2
Active, not recruiting
181 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
1 condition
4 sponsors
9 locations
NCT04907136
Developing and Testing Health Warning Labels on the ENDS Device
NA
Recruiting
210 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06575881
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
N/A
Recruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2029
3 conditions
1 sponsor
1 location
NCT06074497
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.
PHASE1
Active, not recruiting
54 participants
Started: Dec 13, 2023 · Completed: May 30, 2026
1 condition
1 sponsor
3 locations
NCT05837104
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
PHASE2
Recruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06185192
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
NA
Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
PHASE3
Recruiting
765 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2028
1 condition
2 sponsors
132 locations
NCT04322734
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
N/A
Recruiting
500 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
6 conditions
2 sponsors
2 locations
NCT06274710
ODYSSEE Kidney Health Trial
NA
Recruiting
344 participants
Started: Dec 13, 2023 · Completed: Apr 13, 2026
1 condition
4 sponsors
1 location
NCT06315296
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
NA
Recruiting
60 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
5 conditions
1 sponsor
1 location
NCT06003348
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
PHASE4
Recruiting
25 participants
Started: Dec 13, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT06127030
Brief Behavioral Teacher Training for Behavioral Difficulties
NA
Active, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05951959
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
PHASE2
Active, not recruiting
108 participants
Started: Dec 13, 2023 · Completed: Jul 7, 2028
1 condition
1 sponsor
29 locations
NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
PHASE3
Recruiting
1,200 participants
Started: Dec 13, 2023 · Completed: Sep 7, 2032
2 conditions
1 sponsor
189 locations
NCT05734105
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
PHASE3
Recruiting
54 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
70 locations
NCT06647459
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
N/A
Recruiting
200 participants
Started: Dec 13, 2023 · Completed: Jan 1, 2027
2 conditions
1 sponsor
1 location
NCT06263075
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
N/A
Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT05603273
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
NA
Recruiting
40 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT07037888
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
PHASE4
Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06830070
Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy
N/A
Active, not recruiting
70 participants
Started: Dec 13, 2023 · Completed: May 31, 2025
3 conditions
1 sponsor
1 location
NCT06179446
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
PHASE1
Active, not recruiting
157 participants
Started: Dec 13, 2023 · Completed: Sep 25, 2025
3 conditions
1 sponsor
4 locations
NCT06064591
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
N/A
Recruiting
430 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
3 conditions
6 sponsors
3 locations
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
PHASE2
Recruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
6 conditions
3 sponsors
1 location
NCT06168266
Effects of Eccentric Exercise Training in Patients With COPD
NA
Recruiting
170 participants
Started: Dec 13, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT06011109
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PHASE1/PHASE2
Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
2 conditions
1 sponsor
2 locations
NCT06058793
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
PHASE3
Active, not recruiting
138 participants
Started: Dec 13, 2023 · Completed: Oct 7, 2025
1 condition
1 sponsor
56 locations
NCT06021925
Obstetrical History and Anti-HLA Antibodies Level
N/A
Recruiting
6,000 participants
Started: Dec 13, 2023 · Completed: Jun 13, 2024
2 conditions
2 sponsors
1 location
NCT06105931
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
PHASE1
Recruiting
15 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
2 conditions
2 sponsors
1 location
NCT06141473
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
PHASE3
Recruiting
1,600 participants
Started: Dec 13, 2023 · Completed: May 6, 2027
1 condition
1 sponsor
358 locations
NCT06184100
Virtual Self-Management Program for JIA
NA
Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Mar 31, 2026
1 condition
6 sponsors
1 location
NCT07049289
Telemonitoring in Arterial Hypertension
NA
Active, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Sep 9, 2025
2 conditions
1 sponsor
1 location
NCT05894122
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)
N/A
Recruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 12, 2025
2 conditions
1 sponsor
1 location
NCT06149000
Migraine Headache Mitigation Utilizing Avulux
NA
Not yet recruiting
40 participants
Started: Dec 13, 2023 · Completed: Jun 20, 2024
3 conditions
1 sponsor
0 locations
NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
PHASE2
Recruiting
190 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
4 conditions
1 sponsor
51 locations
NCT05839392
Novel Approaches to Target MECOM/EVI1 in AML
NA
Recruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05761223
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
PHASE1/PHASE2
Recruiting
151 participants
Started: Dec 13, 2023 · Completed: Oct 31, 2026
1 condition
2 sponsors
5 locations
NCT06083870
An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC
PHASE1
Recruiting
35 participants
Started: Dec 13, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06170671
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
N/A
Active, not recruiting
250 participants
Started: Dec 13, 2023 · Completed: Sep 30, 2028
1 condition
1 sponsor
19 locations
NCT05174884
Casea S Contraceptive Implants (Casea S) Trial
PHASE1
Active, not recruiting
20 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06164925
Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application
N/A
Recruiting
300 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT06203899
Depression and Suicide Prevention in Adolescents Attending Special Schools
NA
Recruiting
236 participants
Started: Dec 13, 2023 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT06282588
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
PHASE2/PHASE3
Recruiting
493 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2030
1 condition
3 sponsors
11 locations
NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
PHASE3
Active, not recruiting
904 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2029
1 condition
1 sponsor
149 locations
NCT04997993
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
PHASE1
Recruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06092554
Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)
NA
Recruiting
186 participants
Started: Dec 13, 2023 · Completed: Jul 15, 2026
1 condition
2 sponsors
9 locations
Previous
1
More pages
1240
1241
1242
1243
1244
1245
1246
More pages
2369
Next